Volume 19, Issue 1, Pages (January 2016)

Slides:



Advertisements
Similar presentations
Pathogenic and Protective Roles of MyD88 in Leukocytes and Epithelial Cells in Mouse Models of Inflammatory Bowel Disease  Mark J. Asquith, Olivier Boulard,
Advertisements

Volume 34, Issue 5, Pages (May 2011)
Volume 13, Issue 5, Pages (May 2013)
Volume 25, Issue 2, Pages (August 2006)
Volume 43, Issue 4, Pages (October 2015)
Volume 42, Issue 4, Pages (April 2015)
Volume 17, Issue 2, Pages (February 2015)
Volume 6, Issue 5, Pages (November 2009)
Volume 22, Issue 5, Pages e4 (November 2017)
Volume 40, Issue 1, Pages (January 2014)
Volume 20, Issue 2, Pages (July 2017)
Volume 39, Issue 2, Pages (August 2013)
Daniel A. Peterson, Daniel N. Frank, Norman R. Pace, Jeffrey I. Gordon 
Pathogenic and Protective Roles of MyD88 in Leukocytes and Epithelial Cells in Mouse Models of Inflammatory Bowel Disease  Mark J. Asquith, Olivier Boulard,
Volume 16, Issue 2, Pages (July 2016)
Volume 25, Issue 4, Pages (April 2014)
Volume 6, Issue 2, Pages (August 2009)
Jeonghyun Ahn, Sehee Son, Sergio C. Oliveira, Glen N. Barber 
Volume 18, Issue 1, Pages (July 2015)
Volume 10, Issue 5, Pages (November 2011)
Volume 37, Issue 1, Pages (July 2012)
Immunological Consequences of Intestinal Fungal Dysbiosis
Volume 21, Issue 6, Pages e5 (June 2017)
Role of Toll-like Receptors in Spontaneous Commensal-Dependent Colitis
Volume 130, Issue 2, Pages (February 2006)
Volume 21, Issue 4, Pages (October 2017)
Volume 4, Issue 4, Pages (October 2008)
Volume 4, Issue 4, Pages (October 2008)
Volume 17, Issue 5, Pages (May 2015)
Volume 11, Issue 6, Pages (June 2012)
Volume 16, Issue 6, Pages (December 2014)
Volume 17, Issue 5, Pages (October 2016)
Volume 42, Issue 4, Pages (April 2015)
Volume 7, Issue 2, Pages (February 2010)
Volume 36, Issue 2, Pages (February 2012)
Volume 22, Issue 6, Pages e4 (December 2017)
Therapeutic Action of Ghrelin in a Mouse Model of Colitis
Volume 19, Issue 1, Pages (January 2016)
Volume 32, Issue 3, Pages (March 2010)
Volume 19, Issue 2, Pages (February 2016)
Volume 42, Issue 2, Pages (February 2015)
Volume 23, Issue 1, Pages e4 (January 2018)
Volume 135, Issue 2, Pages e2 (August 2008)
Saskia Hemmers, Alexander Y. Rudensky  Cell Reports 
Volume 43, Issue 3, Pages (September 2015)
Volume 36, Issue 2, Pages (February 2012)
Volume 14, Issue 3, Pages (September 2013)
Volume 17, Issue 5, Pages (October 2016)
Volume 39, Issue 6, Pages (December 2013)
Volume 21, Issue 4, Pages (October 2017)
Volume 14, Issue 2, Pages (August 2013)
Volume 38, Issue 3, Pages (March 2013)
Volume 14, Issue 2, Pages (August 2013)
Volume 10, Issue 1, Pages (July 2011)
Daniel A. Peterson, Daniel N. Frank, Norman R. Pace, Jeffrey I. Gordon 
CD4+ Lymphoid Tissue-Inducer Cells Promote Innate Immunity in the Gut
Volume 40, Issue 1, Pages (January 2014)
Myung H. Kim, Elizabeth J. Taparowsky, Chang H. Kim  Immunity 
Volume 46, Issue 4, Pages (April 2017)
Volume 37, Issue 6, Pages (December 2012)
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
Volume 42, Issue 4, Pages (April 2015)
Volume 34, Issue 5, Pages (May 2011)
Volume 41, Issue 2, Pages (August 2014)
Volume 13, Issue 6, Pages (June 2013)
Jeonghyun Ahn, Sehee Son, Sergio C. Oliveira, Glen N. Barber 
Volume 44, Issue 3, Pages (March 2016)
Volume 23, Issue 13, Pages (June 2018)
Volume 44, Issue 3, Pages (March 2016)
Volume 16, Issue 6, Pages (December 2014)
Presentation transcript:

Volume 19, Issue 1, Pages 21-31 (January 2016) Genetic and Metabolic Signals during Acute Enteric Bacterial Infection Alter the Microbiota and Drive Progression to Chronic Inflammatory Disease  Karishma Kamdar, Samira Khakpour, Jingyu Chen, Vanessa Leone, Jennifer Brulc, Thomas Mangatu, Dionysios A. Antonopoulos, Eugene B. Chang, Stacy A. Kahn, Barbara S. Kirschner, Glenn Young, R. William DePaolo  Cell Host & Microbe  Volume 19, Issue 1, Pages 21-31 (January 2016) DOI: 10.1016/j.chom.2015.12.006 Copyright © 2016 Elsevier Inc. Terms and Conditions

Cell Host & Microbe 2016 19, 21-31DOI: (10.1016/j.chom.2015.12.006) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 1 TLR1 Signaling during Acute Gastroenteritis Prevents δ-Proteobacteria Outgrowth (A) Weight change in mice after acute gastroenteritis. Data are the mean ± SEM of three independent experiments (n = 7–9 mice/group). (B) Y. enterocolitica in the LP of WT and TLR1−/− mice over 70 days after initial infection. Data are pooled mean ± SEM from three independent experiments (n = 6–8 mice/group). ∗p < 0.05; ∗∗p < 0.01 Student’s unpaired t test. (C) IL-6 and IL-23 levels in the LP during acute infection and 70 days post-infection. Data are pooled mean ± SEM from three independent experiments (n = 6–8 mice/group). ∗p < 0.05; ∗∗p < 0.01 Student’s unpaired t test. (D) mRNA transcript levels of antimicrobial peptides in distal ileum. Data are the mean ± SEM. n = 5 to 6 mice/group. ∗∗p < 0.01 Student’s unpaired t test. (E) Relative abundance of class- and genera-based classifications of bacterial populations in cecum determined by full-length SSU sequence libraries from TLR1−/− or WT mice. Data are representative of two mice from each group. (F) 16S gene copy numbers of cecal bacteria harvested from WT and TLR1−/− mice 70 days post-GI infection. Data are mean ± SEM (n = 7–10 mice/group). ∗p < 0.05 Student’s unpaired t test. Cell Host & Microbe 2016 19, 21-31DOI: (10.1016/j.chom.2015.12.006) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 2 Altered Microbiota Drives an Inflammatory Phenotype and Prevents Intestinal Healing Germ-free (GF) mice were reconstituted with cecal contents from WT or TLR1−/− mice 70 days (70d) post-infection (p.i.). (A and B) 2 weeks after reconstitution, mucosal scrapings were evaluated for indicated cytokines (A) and transcription factors (B). Data shown is the mean ± SEM protein concentration (A) or fold change (B) compared to untreated GF mice. Data are pooled from two independent experiments (n = 6 and 7 mice/group). ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001 Student’s paired t test. (C and D) WT mice were treated with an antibiotic cocktail (ABX-WT) for 2 weeks and then reconstituted with cecal contents from WT or TLR1−/− mice 70 days post-infection. After 2 weeks, the mice were placed on 2.5% DSS for 7 days followed by normal drinking water for 7 days. The percent change in weight of mice over the 14 days (C) and the individual length of the colon (D) are shown. Data are the average of n = 7–9 mice collected from two separate experiments. ∗p < 0.05 Student’s paired t test. Cell Host & Microbe 2016 19, 21-31DOI: (10.1016/j.chom.2015.12.006) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 3 TLR1 Signaling during Acute GI Infection Prevents Development of Anti-Commensal Immunity (A) Images of H&E-stained proximal colon of WT (left) and TLR1−/− (center right) mice 70 days post-infection by Y. enterocolitica and TLR1−/− infiltrate (right) scale bars are 200 μM and 50 μM, respectively. Data shown are representative images from n = 4 mice/group. (B) Mean concentration of IFN-γ and IL-17 production from colonic lamina propria lymphocytes (LPLs) harvested 70 days after infection by Y. enterocolitica and re-stimulated with indicated bacterial lysate. Data are the mean ± SEM from three independent experiments (n = 6–8 mice/group). ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001 Student’s unpaired t test. (C) Optical density at 600 nm of individual mice (n = 6 mice/group) assayed for anti-IgG and anti-IgA serum reactivity against commensal lysate. ∗p < 0.05 Student’s unpaired t test. (D) The average frequency of anti-commensal serology-positive and -negative pediatric Crohn’s and UC patients. (E) The average frequency of TLR1 I602S genotypes in patients with positive and negative serology for anti-commensal antibodies. (F) The average minor allele (S-variant) frequency (MAF) in serology-positive and -negative Crohn’s disease and UC patients. (G) The average anti-CBir (flagellin) and anti-OmpC antibody concentrations in UC patients homozygous for the S-variant (TLR1 602S), homozygous for the non-variant (TLR1 602I) and heterozygous for the S-variant (TLR1 602S/I). Data are a composite of 220 patients in our pediatric IBD cohort that underwent serological testing. ∗p < 0.05 Student’s paired t test. Cell Host & Microbe 2016 19, 21-31DOI: (10.1016/j.chom.2015.12.006) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 4 Gastroenteritis in the Absence of TLR1 Causes an Increase in Ly6G+CD11c+ Cells Analysis of Peyer’s patches from WT and TLR1−/− mice infected for 3 days with Y. enterocolitica. (A) Flow cytometry plots for Ly6G+CD11c+ cells. Data are representative from five individual mice collected from two separate experiments. (B) Percent survival of mice treated with depleting antibody against Ly6G during Y. enterocolitica infection. (C) Representative histogram of amine-reactive fluorescein (DCFDA) stained cells from the Peyer’s patches 3 days after infection. Data are a representative image from n = 4 mice/group. (D) Fold increase of Nos2 and superoxide dismutase (Sod2) from the Peyer’s patches 3 days after infection. Data are the mean ± SEM from three independent experiments (n = 6–8 mice/group). ∗p < 0.05; ∗∗p < 0.01; Student’s unpaired t test. (E) Tetrathionate levels determined by reverse-phase LC-MS from LP of the terminal ileum. Data are the mean ± SEM from three individual mice/group. Cell Host & Microbe 2016 19, 21-31DOI: (10.1016/j.chom.2015.12.006) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 5 Tetrathionate Respiration Is Necessary for the Outgrowth of D. desulfuricans in the Absence of TLR1 Analysis of WT and TLR1−/− mice after infection with Y. enterocolitica (8081) or the tetrathionate mutant (8081ΔttrBCA). (A and B) (A) Survival (B) bacteria load per mg of tissue in the LP 3 days post-infection. (C) Fold increase in mRNA transcripts of Nos2. Data are the mean ± SEM from two independent experiments (n = 4 to 5 mice/group). ∗p < 0.05; Student’s unpaired t test. (D and E) (D) Tetrathionate levels were measured from the Peyer's patches 3 days after infection. Data are the mean ± SEM of three individual mice per group. (E) Percent of total 16S DNA of D. desulfuricans and (F) Lactobacillus as determined by qPCR of the cecal contents of WT and TLR1−/− mice after infection with Y. enterocolitica or ΔttrBCA mutant. Data are the mean ± SEM pooled from two separate experiments (n = 8–12 mice/group). ∗p < 0.05; ∗∗p < 0.01 Student’s paired t test. Cell Host & Microbe 2016 19, 21-31DOI: (10.1016/j.chom.2015.12.006) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 6 Targeted Microbiota Therapy during Acute GI Infection Prevents Growth of δ-Proteobacteria and Generation of Anti-Commensal Immunity in the Absence of TLR1 WT and TLR1−/− mice were infected with Y. enterocolitica. (A) Percent of Lactobacillus species to total 16S DNA over the 70 days following infection in WT (left) and TLR1−/− (right) mice. Data are the mean ± SEM of n = 4–6 mice/group. (B) WT and TLR1−/− mice were infected with Y. enterocolitica and treated orally with 109 L. reuteri, L. johnsonii or media control on days 4, 6, and 8. D. desulfuricans DNA was measured by qPCR and compared to total 16S DNA. Data are the mean ± SEM pooled from two separate experiments (n = 7–9 mice/group). (C–E) (C) Average weight change, (D) Bacterial burden, and (E) Reg3γ mRNA transcript levels of WT and TLR1−/− mice infected with Y. enterocolitica and treated with L. reuteri or media control on days 4, 6, and 8. Data are the mean ± SEM pooled from two separate experiments (n = 5–7 mice/group). (F–H) (F) OD at 600 nm of anti-commensal IgA antibodies in the serum and (G) average IL-6, IL-23 and (H) IL-17 cytokine production in the LP of L. reuteri-treated WT and TLR1−/− mice. Data are the mean ± SEM pooled from two independent experiments (n = 6 mice/group). ∗p < 0.05; ∗∗p < 0.01 Student’s paired t test. Cell Host & Microbe 2016 19, 21-31DOI: (10.1016/j.chom.2015.12.006) Copyright © 2016 Elsevier Inc. Terms and Conditions